Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report) shares gapped down prior to trading on Friday . The stock had previously closed at $19.80, but opened at $18.45. Ascentage Pharma Group International shares last traded at $18.61, with a volume of 10,088 shares traded.
Ascentage Pharma Group International Trading Down 3.9 %
Ascentage Pharma Group International Company Profile
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
See Also
- Five stocks we like better than Ascentage Pharma Group International
- Growth Stocks: What They Are, Examples and How to Invest
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- 5 Best Gold ETFs for March to Curb Recession Fears
- What is a support level?
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
